Greetings!

Welcome to the Monthly QPS Clinical Newsletter

This month, explore QPS leukopak services, take a closer look inside our state-of-the-art central safety lab, and stay informed with the latest scientific breakthroughs on the QPS blog.

An Essential Tool in the Development of Cell Therapies

Leukopaks offer a rich source of white blood cells, making them instrumental for cutting-edge research and therapeutic development.

From immunology and oncology to infectious disease studies, they provide the cellular foundation for exploring immune function and advancing personalized cell-based treatments.

Whether you're developing immunotherapies or refining experimental models, leukopaks are driving the future of biomedical breakthroughs.

Contact QPS Today to Get a Quote for Your Next Leukopak

QPS: Your Trusted Partner for Safety Testing

The QPS Central Safety Lab offers a full suite of testing services to support every phase of your clinical trial.

From hematology and biochemistry to immunogenicity and female health testing, our all-inclusive approach ensures thorough monitoring of drug safety and patient response—helping you identify risks early and move forward with confidence.

Explore More about the QPS Central Safety Lab

Discover the Future of Science on the QPS Blog

Does Past Flu Exposure Protect Against the Bird Flu?

As avian influenza, or bird flu, continues to circulate globally, researchers are examining the possibility of cross-protection from past seasonal flu…

Animal Research Offers Insight

Clinical Services at QPS

The Role of AI in the Fight Against Cancer

Picture your GPS system of choice — Google Maps, Apple Maps, and the like. You plug in a location, follow the directions, and arrive…

Using AI to Guide Wayward T Cells

Oncology Research at QPS

Subscribe to the QPS Blog

Visit our website www.qps.com

or contact us at infopr@qps.com

for an appointment.

www.qps.com | infopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)